News
1h
Health and Me on MSNNovavax Says FDA Approval Back on Track for Its COVID VaccineNovavax’s vaccine, which is the only protein-based COVID-19 vaccine, is awaiting for its full approval. Once approved, it ...
Los Chargers de Los Ángeles enfrentarán a los Lions de Detroit en el juego anual del Salón de la Fama como parte de la semana ...
Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.
The company says its vaccine is on track for full approval, following delay. Novavax shares soared following the announcement.
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...
23h
Yonhap News Agency on MSNSK bioscience wins patent case against Moderna in S. KoreaSK bioscience Co., the biopharmaceutical arm of South Korea's SK Group, said Wednesday it has achieved a "final victory" in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results